Dow Jones

38,807.33

0.25%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

MTCR

Metacrine (MTCR)

Metacrine Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MTCR

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
23/03/2023	15:36	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:MTCR	Metacrine Inc
23/03/2023	15:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
08/03/2023	05:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MTCR	Metacrine Inc
03/03/2023	16:25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:MTCR	Metacrine Inc
03/03/2023	09:45	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:MTCR	Metacrine Inc
14/02/2023	15:01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MTCR	Metacrine Inc
13/02/2023	07:32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MTCR	Metacrine Inc
27/01/2023	15:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
24/01/2023	16:18	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:MTCR	Metacrine Inc
23/12/2022	15:01	GlobeNewswire Inc.	Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement	NASDAQ:MTCR	Metacrine Inc
19/12/2022	15:00	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
15/12/2022	05:42	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MTCR	Metacrine Inc
08/12/2022	11:09	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:MTCR	Metacrine Inc
16/11/2022	05:25	TipRanks	Metacrine (MTCR) Receives a Hold from H.C. Wainwright	NASDAQ:MTCR	Metacrine Inc
14/11/2022	15:49	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MTCR	Metacrine Inc
14/11/2022	15:41	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:MTCR	Metacrine Inc
14/11/2022	15:38	GlobeNewswire Inc.	Metacrine Reports Third-Quarter 2022 Results	NASDAQ:MTCR	Metacrine Inc
10/11/2022	15:22	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:MTCR	Metacrine Inc
06/09/2022	15:00	Business Wire	Equillium to Acquire Metacrine in All-Stock Transaction	NASDAQ:MTCR	Metacrine Inc
15/08/2022	05:36	TipRanks	H.C. Wainwright Remains a Hold on Metacrine (MTCR)	NASDAQ:MTCR	Metacrine Inc
09/08/2022	15:05	GlobeNewswire Inc.	Metacrine Reports Second-Quarter 2022 Results	NASDAQ:MTCR	Metacrine Inc
13/05/2022	05:37	TipRanks	H.C. Wainwright Maintains Their Hold Rating on Metacrine (MTCR)	NASDAQ:MTCR	Metacrine Inc
12/05/2022	15:05	GlobeNewswire Inc.	Metacrine Reports First-Quarter 2022 Results	NASDAQ:MTCR	Metacrine Inc
03/04/2022	05:46	TipRanks	Metacrine (MTCR) Gets a Hold Rating from RBC Capital	NASDAQ:MTCR	Metacrine Inc
01/04/2022	05:16	TipRanks	H.C. Wainwright Maintains a Hold Rating on Metacrine (MTCR)	NASDAQ:MTCR	Metacrine Inc
30/03/2022	15:19	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:MTCR	Metacrine Inc
30/03/2022	15:05	GlobeNewswire Inc.	Metacrine Reports Fourth-Quarter 2021 Results	NASDAQ:MTCR	Metacrine Inc
24/02/2022	15:05	GlobeNewswire Inc.	Metacrine Announces Executive Leadership Changes	NASDAQ:MTCR	Metacrine Inc
11/02/2022	07:05	GlobeNewswire Inc.	Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan	NASDAQ:MTCR	Metacrine Inc
18/01/2022	19:51	TipRanks	RBC Capital Sticks to Its Hold Rating for Metacrine (MTCR)	NASDAQ:MTCR	Metacrine Inc